About electronic sensor technology

Electronic Sensor Technology, Inc has developed and patented a breakthrough chemical vapor analysis process. This process applies gas chromatography calculations and technology toward a wide variety of industries, including Homeland Security, Life Sciences, Chemical and Petrochemical, Food & Beverage and Environmental. How does gas chromatography work? With rapid, accurate analysis of chemical odors and vapors, this patented technology helps to provide real-time analysis for quick response solutions.

KEY CAPABILITIES

zNose® is highly capable of assisting the healthcare industry with its distinctive features. It efficiently renders the chemical composition of blood, urine and other diagnostic bodily fluids. Let’s take a look at some of the features to know more about zNose®:

  • Gives full chemical profile of body fluids
  • Identifies the odors from blood, urine etc.
  • Possesses tunable specificity
  • Expandable library of over 700 chemicals signatures
  • Ondcp validated
  • Uses ultra-fast gas chromatography

THE zNose® HISTORY

Better and faster than other electronic sniffers in the market. Understands customer needs & fits into a wide range of industries.There is a big list of reasons why zNose® is the most trusted instrument in the market today.

Watch: How zNose® Works?

BUILDING SECURITY

zNose® monitors the air chemistry within buildings and compares it with the building's normal background signature. It recognizes the threatening odors and helps to keep the security at buildings intact. It also provides aid to:

  • Screen and monitor public buildings and transportation facilities
  • Analyze suspicious odors and hazardous industrial materials
  • Provide sensitive and rapid warning for fixed sites such as, government buildings etc.
  • Keep a check on ambient odor of subway stations, financial centers and high-value industries

Watch: 5 Key concerns of Homeland Security and its solutions

Watch: Disruptive Sensor Technology for Homeland Security

Watch: Gas Chromatography Solutions for Screening Cargos

Go to article: Home | Risky Business: Reporting Medical Device FailuresGo to article: Biointeractions Company Insight Go to article: Biointeractions Go to article: In This Issue Go to article: Formacoat Company InsightGo to article: FormacoatGo to article: Contents Go to article: MPS Microsystems Company InsightGo to article: MPS MicrosystemsGo to article: NewsGo to article: SartoriusGo to article: MikronGo to article: The Medical Industry BriefingGo to article: Protomatic Medical Company InsightGo to article: Protomatic MedicalGo to article: Regulating brain-device interface dilemmasGo to article: Telemed Company InsightGo to article: TelemedGo to article: Selling into the NHS: HEE’s top tips for medtech companiesGo to article: Klingel Company Insight Go to article: KlingelGo to article: Cap BiomaterialsGo to article: Israel: a medtech innovation hub for the worldGo to article: Electronic Sensor TechnologyGo to article: Braxton Manufacturing Go to article: US medical device tax: should it be gone for good?Go to article: Micro Systems TechnologiesGo to article: Hidden figures: lifting the lid on medical device failure reportingGo to article: IMT Company InsightGo to article: IMTGo to article: Take a deep breath: this could be the future of cancer diagnosisGo to article: Smiths InterconnectGo to article: Current Health gains FDA clearance for in-home remote patient monitoringGo to article: Design Standards CorporationGo to article: 5G will revolutionise healthcareGo to article: ParmacoGo to article: Approval of ADHD neurostimulation device clears path for treatments of related neurological disordersGo to article: Mi3 Medical IntelligenceGo to article: FDA warns against off-label use of Stryker’s Wingspan stentGo to article: Virtual reality heralds and exciting new era for treatmentGo to article: Erdmann Design SwitzerlandGo to article: EventsGo to article: Next Issue